These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26398341)

  • 21. Impact of Visceral Obesity on Microvascular Invasion in Hepatocellular Carcinoma.
    Arsenii N; Piardi T; Diébold MD; Chenard MP; Drame M; De Mestier L; Hoeffel C; Pessaux P; Sommacale D; Thiéfin G
    Cancer Invest; 2016 Jul; 34(6):271-8. PubMed ID: 27355681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging?
    Xu P; Zeng M; Liu K; Shan Y; Xu C; Lin J
    J Gastroenterol Hepatol; 2014 Feb; 29(2):330-6. PubMed ID: 24033853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can microvascular invasion in hepatocellular carcinoma be predicted by diagnostic imaging? A critical review.
    Reginelli A; Vacca G; Segreto T; Picascia R; Clemente A; Urraro F; Serra N; Vanzulli A; Cappabianca S
    Future Oncol; 2018 Dec; 14(28):2985-2994. PubMed ID: 30084651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
    Harimoto N; Yoshida Y; Kurihara T; Takeishi K; Itoh S; Harada N; Tsujita E; Yamashita YI; Uchiyama H; Soejima Y; Ikegami T; Yoshizumi T; Kawanaka H; Ikeda T; Shirabe K; Saeki H; Oki E; Kimura Y; Maehara Y
    Transplant Proc; 2015 Apr; 47(3):703-4. PubMed ID: 25819732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microvascular invasion patterns affect survival in hepatocellular carcinoma patients after second hepatectomy.
    Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B; Chen KF
    J Surg Res; 2016 Jan; 200(1):82-90. PubMed ID: 26259778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood oxygen level-dependent liver MRI: can it predict microvascular invasion in HCC?
    Jhaveri KS; Cleary SP; Fischer S; Haider MA; Pargoankar V; Khalidi K; Moshonov H; Gallinger S
    J Magn Reson Imaging; 2013 Mar; 37(3):692-9. PubMed ID: 23125092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative computed tomography and serum α-fetoprotein to predict microvascular invasion in hepatocellular carcinoma.
    Zhang W; Liu L; Wang P; Wang L; Liu L; Chen J; Su D
    Medicine (Baltimore); 2018 Jul; 97(27):e11402. PubMed ID: 29979435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma?
    Renzulli M; Brocchi S; Cucchetti A; Mazzotti F; Mosconi C; Sportoletti C; Brandi G; Pinna AD; Golfieri R
    Radiology; 2016 May; 279(2):432-42. PubMed ID: 26653683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined AFP-CRUT with microvascular invasion accurately predicts mortality risk in patients with hepatocellular carcinoma following curative liver resection.
    Huang GQ; Zhu GQ; Huang S; You J; Shi KQ; Hu B; Ruan LY; Zhou MT; Braddock M; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1127-38. PubMed ID: 26186642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma.
    Wang W; Guo Y; Zhong J; Wang Q; Wang X; Wei H; Li J; Xiu P
    Sci Rep; 2021 Jan; 11(1):2415. PubMed ID: 33510294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal mRNA in plasma serves as a predictive marker for microvascular invasion in hepatocellular carcinoma.
    Xin Z; Chen H; Xu J; Zhang H; Peng Y; Ren J; Guo Q; Song J; Jiao L; You L; Bai L; Wei Y; Zhou J; Ying B
    J Gastroenterol Hepatol; 2024 Oct; 39(10):2228-2238. PubMed ID: 38972728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a novel predictive scoring model for microvascular invasion in patients with hepatocellular carcinoma.
    Zhao H; Hua Y; Dai T; He J; Tang M; Fu X; Mao L; Jin H; Qiu Y
    Eur J Radiol; 2017 Mar; 88():32-40. PubMed ID: 28189206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies.
    Beaufrère A; Caruso S; Calderaro J; Poté N; Bijot JC; Couchy G; Cauchy F; Vilgrain V; Zucman-Rossi J; Paradis V
    J Hepatol; 2022 Feb; 76(2):343-352. PubMed ID: 34624411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Need for normalization: the non-standard reference standard for microvascular invasion diagnosis in hepatocellular carcinoma.
    Hu HT; Wang Z; Kuang M; Wang W
    World J Surg Oncol; 2018 Mar; 16(1):50. PubMed ID: 29514674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research progress in radiomics based on CT and MRI images for prediction of microvascular invasion in hepatocellular carcinoma].
    Liu YN; Xu YK; Deng SY; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2022 Aug; 30(8):809-813. PubMed ID: 36207937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma.
    Kaibori M; Ishizaki M; Matsui K; Kwon AH
    J Surg Oncol; 2010 Oct; 102(5):462-8. PubMed ID: 20872949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
    Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined serum CXCL8, CXCL9 and CXCL13 tests for the prediction of microvascular invasion in hepatocellular carcinoma.
    Liu H; Bai Y; Li F; Tian Z
    Biomark Med; 2023 Mar; 17(5):265-272. PubMed ID: 37218545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.